Mapping regional funding for COVID-19 research in the Asia-Pacific region
-
Published:2023-11
Issue:11
Volume:8
Page:e013551
-
ISSN:2059-7908
-
Container-title:BMJ Global Health
-
language:en
-
Short-container-title:BMJ Glob Health
Author:
Antonio EmiliaORCID,
Pulik Nicolas,
Lee Jieun,
Soni Tanu,
Hagen Hans-Eckhardt,
Ryu Choong-Min,
Norton Alice
Abstract
IntroductionThe Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) is a network of funders supporting research on infectious diseases of epidemic/pandemic potential. GloPID-R is establishing regional hubs to strengthen stakeholder engagement particularly among low-income and middle-income countries. The first pilot hub, led from Republic of Korea (South Korea), has been launched in the Asia-Pacific region, a region highly prone to outbreaks of emerging infectious diseases. We present findings of mapping research undertaken in support of the hub’s development.MethodsWe analysed five COVID-19 research databases in September 2022 to identify research funders and intermediary funding sources supporting research in infectious diseases in the Asia-Pacific region. This was complemented with an in-depth analysis of the UK Collaborative on Development Research (UKCDR) and GloPID-R COVID-19 Research Project Tracker to assess the alignment of funded projects in the region to the WHO COVID-19 research priorities.ResultsWe identified 453 funders and funding sources supporting COVID-19 research in the Asia-Pacific Region including public, private and philanthropic organisations and universities. However, these organisations were clustered in few countries in the region. The in-depth analysis of the UKCDR and GloPID-R COVID-19 Research project Tracker found limited research involving Asia-Pacific countries with the 117 funders supporting these projects investing at least US$604m in COVID-19 research in the region. Social Sciences was the dominant theme on which funded projects focused whereas the priority areas with the least number of projects were research on ‘animal and environmental health’ and ‘ethics considerations for research’.ConclusionOur analyses show the diversity of funding sources for research on infectious diseases in the Asia-Pacific region. Engagement between multiple actors in the health research system is likely to promote enhanced coordination for greater research impact. GloPID-R’s Asia-Pacific regional hub aims to support activities for the enhancement of preparedness for outbreaks of emerging infectious diseases in the region.
Funder
UK Research and Innovation
Horizon 2020 Framework Programme
Ministry of Science and ICT, South Korea
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference36 articles.
1. WHO/SEARO/WPRO . Asia pacific strategy for emerging diseases. WHO Regional Office for South-East Asia, 2005. Available: https://apps.who.int/iris/handle/10665/204797
2. WHO/WPRO . Asia Pacific Strategy for Emerging Diseases and Public Health Emergencies (APSED III): Advancing implementation of the International Health Regulations. Manila, Philippines: World Health Organization Regional Office for the Western Pacific, 2017. Available: https://apps.who.int/iris/rest/bitstreams/1147924/retrieve
3. Human Mobility and the Global Spread of Infectious Diseases: A Focus on Air Travel
4. Emerging infectious diseases in southeast Asia: regional challenges to control
5. Shariff M . Nipah virus infection: A review. Epidemiol Infect 2019;147:e95. doi:10.1017/S0950268819000086